Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyWellfleet High-Cost Drug Coverage Update | OpenPay…
    Ask Trek AI about this page
    CurrentWellfleetPolicy GL-023

    High-Cost Drug Reimbursement

    Customize your policy alerts

    Sign up for wellfleet Policy GL-023 alerts

    Get alerted when Policy GL-023 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs Wellfleet reimbursement for high-cost drugs billed under a member's medical benefit when the drugs are separately reimbursed from other claim line items. It applies to providers submitting claims for applicable Wellfleet plans, subject to the member's benefit document, provider agreement, applicable mandates, and any required precertification.

    Policy Summary
    PayerWellfleet
    PolicyHigh-Cost Drug Reimbursement
    Policy CodePolicy GL-023
    Change TypeNo material change
    Effective DateAug 1, 2023
    Next Review DateFeb 1, 2024
    Key ActionObtain any required precertification review and approval under the member's plan before billing the high-cost drug.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    >$10,000Cost threshold per 30-day supply for a high-cost drug
    2x AWPMaximum reimbursement methodology for eligible high-cost drugs
    4Documented eligibility conditions for reimbursement at the stated methodology
    Medical benefitBenefit under which covered high-cost drugs must be billed

    Eligibility for High-Cost Drug Reimbursement

    Eligibility for High-Cost Drug Reimbursement

    Wellfleet will reimburse up to two times the listed Average Wholesale Price (AWP) for High-Cost Drugs submitted under a member's Medical Benefit when ALL of the following conditions are met. Self-Administered drugs are subject to the Self-Administered Medications Guideline first; if that guideline is not applicable, this High-Cost Drug guideline is reviewed. Medical records may be requested to support billed dosing amounts.

    ALL of the following

    • The High-Cost Drug is a prescription medication costing over $10,000 per 30-day supply that requires special handling, administration, or monitoring and is covered under both medical and pharmacy benefits, typically for complex and/or chronic conditions.
    • The High-Cost Drug is a covered Medical Benefit under an eligible member's Plan.
    • The High-Cost Drug is submitted as an individual line item on a medical claim.
    Policy Summary
    PayerWellfleet
    PolicyHigh-Cost Drug Reimbursement
    Policy CodePolicy GL-023
    Change TypeNo material change
    Effective DateAug 1, 2023
    Next Review DateFeb 1, 2024
    Key ActionObtain any required precertification review and approval under the member's plan before billing the high-cost drug.
    SourceLink
    On This Page
    Eligibility for High-Cost Drug ReimbursementCoding and Reimbursement ParametersProvider Billing and Documentation RequirementsHigh-Cost Drug Definition

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    The High-Cost Drug is appropriately coded as specifically as possible at the time of billing.
  1. The claim payment methodology dictates that the High-Cost Drug be reimbursed separately from the other line items, including percent-of-charges, Reasonable, Customary & Usual, or another methodology with an appropriate Revenue Code carve-out payment.
  2. The High-Cost Drug has undergone any required Precertification Review and Approval under the member's Plan.
  3. Coding and Reimbursement Parameters

    High-cost drug code listmixed
    No codes listed
    Medical claim line-item and revenue-code carve-out billingRevenueCovered
    No codes listed
    High-Cost Drug Price Threshold
    Cost thresholdOver $10,000 per 30-day supply
    Applies toHigh-Cost Drugs submitted for reimbursement through a member’s medical benefit
    Payment contextApplies when the High-Cost Drug is reimbursed separately from other claim line items
    Maximum Reimbursement
    Maximum reimbursementUp to two times the listed Average Wholesale Price (AWP)
    BenefitMember’s Medical Benefit
    Eligibility conditionThe High-Cost Drug must be a covered Medical Benefit under an eligible member’s Plan

    Provider Billing and Documentation Requirements

    Documentation Required

    Submit Accurate Claims and Supporting Documentation

    Providers are responsible for submitting accurate claims to Wellfleet. Wellfleet may request supporting documentation for submitted claims, including provider records.

    Prior Authorization

    Required Precertification

    Before billing a High-Cost Drug, ensure it has undergone any required precertification review and approval under the member’s plan.

    Documentation Required

    Document Billed Dosing

    Be prepared to provide medical records supporting the dosing amounts billed for a High-Cost Drug if requested by Wellfleet.

    Billing Rule

    Submit and Code Drug Line Items Separately

    Report each High-Cost Drug as an individual line item on the medical claim and code it appropriately, as specifically as possible, at the time of billing.

    Step Therapy

    Apply Self-Administered Drug Guidance First

    Apply the Self-Administered Medications Guideline first for self-administered drugs. If that guideline is not applicable, Wellfleet will review the drug under the High-Cost Drugs Guideline.

    • Self-Administered Medications Guideline: https://wellfleetstudent.com/providers/

    High-Cost Drug Definition

    High-Cost Drug
    DefinitionPrescription medications that cost over $10,000 per 30-day supply
    Special requirementsRequire special handling, administration, or monitoring
    CoverageCovered under both medical and pharmacy benefits
    Typical useUsually treat complex and/or chronic conditions